These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 38027142)
1. Prevalence and prognostic significance of main metabolic risk factors in primary biliary cholangitis: a retrospective cohort study of 789 patients. Zhao DT; Yan HP; Han Y; Zhang WM; Zhao Y; Liao HY Front Endocrinol (Lausanne); 2023; 14():1142177. PubMed ID: 38027142 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507 [TBL] [Abstract][Full Text] [Related]
3. The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis. Liu X; Xu H; Zhan M; Niu J Med Sci Monit; 2019 Aug; 25():6174-6180. PubMed ID: 31420961 [TBL] [Abstract][Full Text] [Related]
4. Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitis. Minuk GY; Iliant V; Zhou N; Kaita KD; Wong SG; Peretz D; Uhanova J Liver Int; 2018 Jun; 38(6):1110-1116. PubMed ID: 29193593 [TBL] [Abstract][Full Text] [Related]
5. Concomitant gallstone disease was not associated with long-term outcomes in ursodeoxycholic acid-treated patients with primary biliary cholangitis. Chen S; Li MQ; Li BE; Lv TT; Li SX; Shan S; Li M; Kong YY; Zhang D; Ma H; Ou XJ; You H; Duan WJ; Jia JD J Dig Dis; 2023; 24(6-7):419-426. PubMed ID: 37464723 [TBL] [Abstract][Full Text] [Related]
6. The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210. Yang F; Yang Y; Wang Q; Wang Z; Miao Q; Xiao X; Wei Y; Bian Z; Sheng L; Chen X; Qiu D; Fang J; Tang R; Gershwin ME; Ma X Aliment Pharmacol Ther; 2017 Mar; 45(5):733-743. PubMed ID: 28083929 [TBL] [Abstract][Full Text] [Related]
8. The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis. Chen Q; Zhong R; Wang Y; Kui Y; Wen X; Huang J; Jin Q Dig Dis; 2023; 41(6):946-956. PubMed ID: 37321186 [TBL] [Abstract][Full Text] [Related]
9. The impact of primary biliary cholangitis on non-alcoholic fatty liver disease. Iluz-Freundlich D; Uhanova J; Grubert Van Iderstine M; Minuk GY Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):565-570. PubMed ID: 32541239 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome. Braga MH; Cançado GGL; Bittencourt PL; Couto CA; Guedes LV; Lima AMC; Ferraz MLG; Villela-Nogueira CA; Nardelli MJ; Faria LC; Gomes NMF; Oliveira EMG; Rotman V; Oliveira MB; da Cunha SMCF; Cunha-Silva M; Mendes LSC; Ivantes CAP; Codes L; de Almeida E Borges VF; Pace FHL; Pessoa MG; Signorelli IV; Coral GP; Filho JG; Chagas AL; Terrabuio DRB; Cançado ELR; Ann Hepatol; 2023; 28(4):101105. PubMed ID: 37088418 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and prognosis of concomitant systemic lupus erythematosus and primary biliary cholangitis. Cheng C; Wang Z; Wang L; Zhao J; Wang Q; Tian X; Li M; Zeng X Clin Rheumatol; 2021 May; 40(5):1819-1826. PubMed ID: 33067770 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis. Corpechot C Clin Liver Dis; 2022 Nov; 26(4):681-689. PubMed ID: 36270723 [TBL] [Abstract][Full Text] [Related]
14. Laboratory risk factors for coexistent primary biliary cholangitis in patients with Sjögren's syndrome: a retrospective study. Gao X; Xiao G; Yang F; Dou R; Xue M; Zhang Y; Zheng Z; Ding J BMC Gastroenterol; 2023 Jun; 23(1):220. PubMed ID: 37365494 [TBL] [Abstract][Full Text] [Related]
15. Identifying Patients With Primary Biliary Cholangitis and Cirrhosis Using Administrative Data in a National Cohort. John BV; Bastaich D; Dahman B; Pharmacoepidemiol Drug Saf; 2024 Oct; 33(10):e70013. PubMed ID: 39415072 [TBL] [Abstract][Full Text] [Related]
16. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome. Kasmari AJ; Welch A; Liu G; Leslie D; McGarrity T; Riley T Am J Med; 2017 Jun; 130(6):746.e1-746.e7. PubMed ID: 28109969 [TBL] [Abstract][Full Text] [Related]